multiple myeloma
Showing 1 - 25 of 1,882
Multiple Myeloma Trial in Paris (Idecabtagene vicleucel, Not treated)
Active, not recruiting
- Multiple Myeloma
- Idecabtagene vicleucel
- Not treated
-
Paris, FranceDESCAR-T Registry
Nov 27, 2023
Multiple Myeloma Cells From miRNAs Released From B Cells, and
Recruiting
- Multiple Myeloma
-
Aviano, Pordenone, ItalyCentro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Nov 23, 2023
Determine the Optimal Initial Therapy for Multiple Myeloma
Recruiting
- Multiple Myeloma
- Non-Interventional Study
-
Scottsdale, Arizona
- +3 more
Nov 22, 2023
Clinical Pathways for Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Multiple Myeloma Without Mention of Remission
- Multiple Myeloma Pathway
- +2 more
- (no location specified)
Nov 27, 2023
Multiple Myeloma Trial in Rochester (behavioral, other, procedure)
Not yet recruiting
- Multiple Myeloma
- Supportive Care (home-based physical activity)
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,
Not yet recruiting
- Multiple Myeloma
- Renal Failure
- Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
-
Augusta, GeorgiaGeorgia Cancer Center-Augusta University
Nov 16, 2023
Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)
Not yet recruiting
- Refractory Multiple Myeloma
- +2 more
-
Boston, Massachusetts
- +2 more
Nov 17, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)
Recruiting
- Multiple Myeloma
- APRIL-BAFF-Bicephali CAR-T cells
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 14, 2023
Identify Barriers to Cellular Therapies for People With Plasma
Recruiting
- Multiple Myeloma
- Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Nov 6, 2023
Multiple Myeloma Trial (CM313 injection)
Not yet recruiting
- Multiple Myeloma
- CM313 injection
- (no location specified)
Nov 6, 2023
MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With
Not yet recruiting
- Multiple Myeloma
- Minimal Residual Disease
- (no location specified)
Nov 1, 2023
Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Frailty
- (no location specified)
Oct 30, 2023
Multiple Myeloma Trial in Houston (Belumosudil mesylate)
Not yet recruiting
- Multiple Myeloma
- Belumosudil mesylate
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2023
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)
Not yet recruiting
- Multiple Myeloma
- Iberdomide
- Daratumumab/rHuPH20 Co-formulation
- (no location specified)
Oct 25, 2023
Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
-
Miami, FloridaUniversity of Miami
Oct 20, 2023
Multiple Myeloma Prognostic Indices
Recruiting
- Multiple Myeloma
- Hematologic Diseases
- blood viscosity , albumin / fibrinogen ratio and red cell distribution
-
Assiut, EgyptAssiut University hospital
Oct 17, 2023
Multiple Myeloma Trial in Wollongong (IBI3003)
Not yet recruiting
- Multiple Myeloma
-
Wollongong, New South Wales, AustraliaWollongong Private Hospital
Oct 18, 2023